|Articles|April 1, 2013
- Pharmaceutical Executive-04-01-2013
- Volume 0
- Issue 0
PE, April 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
almost 13 years ago
Country Report: Belgiumalmost 13 years ago
On-Market Pricing Strategiesalmost 13 years ago
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?almost 13 years ago
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumphalmost 13 years ago
Pfizer's Quality by Design Approach to Trial Managementalmost 13 years ago
Woman of the Year 2013almost 13 years ago
Key to Brand Positioning: Look Inside Your Heartalmost 13 years ago
Full Disclosure for PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
4
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
5